ERK5 is a critical mediator of inflammation-driven cancer.
about
ERK5 and Cell Proliferation: Nuclear Localization Is What MattersA novel IL-17 signaling pathway controlling keratinocyte proliferation and tumorigenesis via the TRAF4-ERK5 axis.ERK5 kinase activity is dispensable for cellular immune response and proliferation.Absence of ERK5/MAPK7 delays tumorigenesis in Atm-/- mice.Cripto-1: an extracellular protein - connecting the sequestered biological dots.Metabolomics Analysis of Hormone-Responsive and Triple-Negative Breast Cancer Cell Responses to Paclitaxel Identify Key Metabolic Differences.SATB2 suppresses gastric cancer cell proliferation and migration.MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism.Increased T-cell Infiltration Elicited by Erk5 Deletion in a Pten-Deficient Mouse Model of Prostate Carcinogenesis.Can tumor cells proliferate without ERK5?Extracellular signal regulated kinase 5 and inflammasome in progression of mesothelioma.Identification of potential target genes for ankylosing spondylitis treatment.Myeloid ERK5 deficiency suppresses tumor growth by blocking protumor macrophage polarization via STAT3 inhibition.The Proteasome Inhibitor Bortezomib Inhibits Inflammatory Response of Periodontal Ligament Cells and Ameliorates Experimental Periodontitis in Rats.TRAF1 Is Critical for DMBA/Solar UVR-Induced Skin Carcinogenesis.The transcription factor FOXF1 promotes prostate cancer by stimulating the mitogen-activated protein kinase ERK5.
P2860
Q28078572-30D1DBD9-AA49-4E91-B3C9-83E5553424C9Q36080701-AA090836-124A-40CF-8023-54AAF17C370FQ37369392-A0B94DD5-449F-4956-93D6-192AAB56AA38Q37688789-EC113CC9-4090-49DE-B47D-ADB32DF60FF2Q38578005-80F57FAC-BF17-436C-B7BC-3E5F099C18B9Q38756385-49D3AA2F-ABE6-4134-B494-E8BC3BD12BD6Q38824327-4EE83215-293B-45DB-B4AB-7C1245F79878Q41610131-73014B48-62B9-41D3-BDDC-72986F862CEBQ42051316-4945C713-3CAD-42A7-BAC3-C350E5C83B89Q42857409-774F1592-0DCA-4CE8-B617-765962561367Q49226710-94562EE2-D2D1-4031-A3B4-29DC063D1E32Q49712215-52BDCEB2-AA79-4669-8A22-F5AE2457CF31Q50420763-DD03BCC9-1EF9-4AA7-9892-DCD5669B5A53Q51075720-29219999-8CB6-448A-ABE8-AFA8D0BE878CQ51164416-AE292613-6953-4CF1-A58D-F331975D941EQ51337382-89A32755-7F88-44BD-9997-BA02C526DD29
P2860
ERK5 is a critical mediator of inflammation-driven cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
ERK5 is a critical mediator of inflammation-driven cancer.
@en
ERK5 is a critical mediator of inflammation-driven cancer.
@nl
type
label
ERK5 is a critical mediator of inflammation-driven cancer.
@en
ERK5 is a critical mediator of inflammation-driven cancer.
@nl
prefLabel
ERK5 is a critical mediator of inflammation-driven cancer.
@en
ERK5 is a critical mediator of inflammation-driven cancer.
@nl
P2093
P2860
P50
P1433
P1476
ERK5 is a critical mediator of inflammation-driven cancer.
@en
P2093
Allan M Jordan
Diana Perez-Madrigal
James R Hitchin
P2860
P304
P356
10.1158/0008-5472.CAN-13-3043
P407
P577
2015-02-03T00:00:00Z